To fully benefit from the vast quantities of data from TCGA, tools for easy data visualisation and analysis must be developed for use of the non-computational scientist. Our panel of experts discuss TCGA data and the tools needed to make sense of it.
Data is at the heart of applicable genomics. As the volume and depth of genomic data grows, bioinformaticians are translating the data into interpretable patterns leading to new biological insight.
The largest study to date launched to analyse the genetics of prostate cancer has unlocked 80 new drug targets, opening up a broad range of avenues for the design of new treatments.
13 European countries have committed to work together and ensure secure and authorised cross-border access to genomic and other health data.
Researchers around the globe can now access thousands of paediatric cancer genomic datasets, thanks to a new cloud-based initiative.
India becomes the eighth largest state seeking to build a blockchain-based DNA database of all 50 million of its citizens.
Repositive, has successfully concluded the pilot phase of its data-sharing platform for PDX cancer models and is now extending the scope of the platform to include a wider range of translational cancer models.
Comparison of Single Nucleotide Variants in Sequencing Data Produced by Illumina and Oxford Nanopore Technologies.
Come hear from David Grieg, Bioinformatician at Public Health England to learn more about the application of the MinION for the surveillance of Shiga toxin-producing Escherichia coli O157:H7.
Dr Joan O’Brien, chair of the University of Pennsylvania’s Department of Ophthalmology, Scheie Eye Institute, Philadelphia, and primary investigator of POAAGG, joins our panel of experts on April 10th to discuss bias in genetic studies and what is being done to remove it.
Access to electronic patient data has huge potential, and with the federal Centers for Medicare and Medicaid Services calling for entry, we could soon be seeing the impact in the healthcare system.